Cite
HARVARD Citation
Lengacher, R. et al. (2021). Organometallic small molecule kinase inhibitors – direct incorporation of Re and 99mTc into Opaganib®. Chemical communications. 57 (98), pp. 13349-13352. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lengacher, R. et al. (2021). Organometallic small molecule kinase inhibitors – direct incorporation of Re and 99mTc into Opaganib®. Chemical communications. 57 (98), pp. 13349-13352. [Online].